aluates Reports

$ 0.0

Automative

Global Drug Repurposing Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-23J5563

Global Drug Repurposing Market Insights and Forecast to 2028

BUY CHAPTERS

Global Drug Repurposing Market Research Report 2025

Code: QYRE-Auto-23J5563

Report

September 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novartis

Astellas Pharma

Biovista Inc

AbbVie

Allergan plc

NuMedii

Drug Repurposing Market Size

The global market for Drug Repurposing was valued at US$ 26730 million in the year 2024 and is projected to reach a revised size of US$ 32560 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Drug Repurposing Market

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Repurposing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing.

The Drug Repurposing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Repurposing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Repurposing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Repurposing Market Report

Report Metric	Details
Report Name	Drug Repurposing Market
Accounted market size in year	US$ 26730 million
Forecasted market size in 2031	US$ 32560 million
CAGR	2.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oncology CNS Diseases Neurodegenerative Diseases Others
Segment by Application	Hospitals Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, NuMedii
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repurposing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Repurposing Market growing?

Ans: The Drug Repurposing Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Drug Repurposing Market size in 2031?

Ans: The Drug Repurposing Market size in 2031 will be US$ 32560 million.

Who are the main players in the Drug Repurposing Market report?

Ans: The main players in the Drug Repurposing Market are Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, NuMedii

What are the Application segmentation covered in the Drug Repurposing Market report?

Ans: The Applications covered in the Drug Repurposing Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Drug Repurposing Market report?

Ans: The Types covered in the Drug Repurposing Market report are Oncology, CNS Diseases, Neurodegenerative Diseases, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oncology

1.2.3 CNS Diseases

1.2.4 Neurodegenerative Diseases

1.2.5 Others

1.3 Market by Application

1.3.1 Global Drug Repurposing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Repurposing Market Perspective (2020-2031)

2.2 Global Drug Repurposing Growth Trends by Region

2.2.1 Global Drug Repurposing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Repurposing Historic Market Size by Region (2020-2025)

2.2.3 Drug Repurposing Forecasted Market Size by Region (2026-2031)

2.3 Drug Repurposing Market Dynamics

2.3.1 Drug Repurposing Industry Trends

2.3.2 Drug Repurposing Market Drivers

2.3.3 Drug Repurposing Market Challenges

2.3.4 Drug Repurposing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Repurposing Players by Revenue

3.1.1 Global Top Drug Repurposing Players by Revenue (2020-2025)

3.1.2 Global Drug Repurposing Revenue Market Share by Players (2020-2025)

3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Repurposing Revenue

3.4 Global Drug Repurposing Market Concentration Ratio

3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2024

3.5 Global Key Players of Drug Repurposing Head office and Area Served

3.6 Global Key Players of Drug Repurposing, Product and Application

3.7 Global Key Players of Drug Repurposing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repurposing Breakdown Data by Type

4.1 Global Drug Repurposing Historic Market Size by Type (2020-2025)

4.2 Global Drug Repurposing Forecasted Market Size by Type (2026-2031)

5 Drug Repurposing Breakdown Data by Application

5.1 Global Drug Repurposing Historic Market Size by Application (2020-2025)

5.2 Global Drug Repurposing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Repurposing Market Size (2020-2031)

6.2 North America Drug Repurposing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Repurposing Market Size by Country (2020-2025)

6.4 North America Drug Repurposing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Repurposing Market Size (2020-2031)

7.2 Europe Drug Repurposing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Repurposing Market Size by Country (2020-2025)

7.4 Europe Drug Repurposing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Repurposing Market Size (2020-2031)

8.2 Asia-Pacific Drug Repurposing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Repurposing Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Repurposing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Repurposing Market Size (2020-2031)

9.2 Latin America Drug Repurposing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Repurposing Market Size by Country (2020-2025)

9.4 Latin America Drug Repurposing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Repurposing Market Size (2020-2031)

10.2 Middle East & Africa Drug Repurposing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Repurposing Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Repurposing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astellas Pharma

11.1.1 Astellas Pharma Company Details

11.1.2 Astellas Pharma Business Overview

11.1.3 Astellas Pharma Drug Repurposing Introduction

11.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2020-2025)

11.1.5 Astellas Pharma Recent Development

11.2 Biovista

11.2.1 Biovista Company Details

11.2.2 Biovista Business Overview

11.2.3 Biovista Drug Repurposing Introduction

11.2.4 Biovista Revenue in Drug Repurposing Business (2020-2025)

11.2.5 Biovista Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Drug Repurposing Introduction

11.3.4 Novartis Revenue in Drug Repurposing Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Drug Repurposing Introduction

11.4.4 AbbVie Revenue in Drug Repurposing Business (2020-2025)

11.4.5 AbbVie Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Drug Repurposing Introduction

11.5.4 Pfizer Revenue in Drug Repurposing Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Allergan

11.6.1 Allergan Company Details

11.6.2 Allergan Business Overview

11.6.3 Allergan Drug Repurposing Introduction

11.6.4 Allergan Revenue in Drug Repurposing Business (2020-2025)

11.6.5 Allergan Recent Development

11.7 NuMedii

11.7.1 NuMedii Company Details

11.7.2 NuMedii Business Overview

11.7.3 NuMedii Drug Repurposing Introduction

11.7.4 NuMedii Revenue in Drug Repurposing Business (2020-2025)

11.7.5 NuMedii Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Novartis

Astellas Pharma

Biovista Inc

AbbVie

Allergan plc

NuMedii

List of Tables

Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oncology

Table 3. Key Players of CNS Diseases

Table 4. Key Players of Neurodegenerative Diseases

Table 5. Key Players of Others

Table 6. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drug Repurposing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Drug Repurposing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Drug Repurposing Market Share by Region (2020-2025)

Table 10. Global Drug Repurposing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Drug Repurposing Market Share by Region (2026-2031)

Table 12. Drug Repurposing Market Trends

Table 13. Drug Repurposing Market Drivers

Table 14. Drug Repurposing Market Challenges

Table 15. Drug Repurposing Market Restraints

Table 16. Global Drug Repurposing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Drug Repurposing Market Share by Players (2020-2025)

Table 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2024)

Table 19. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Drug Repurposing, Headquarters and Area Served

Table 22. Global Key Players of Drug Repurposing, Product and Application

Table 23. Global Key Players of Drug Repurposing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drug Repurposing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Drug Repurposing Revenue Market Share by Type (2020-2025)

Table 27. Global Drug Repurposing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Drug Repurposing Revenue Market Share by Type (2026-2031)

Table 29. Global Drug Repurposing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Drug Repurposing Revenue Market Share by Application (2020-2025)

Table 31. Global Drug Repurposing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Drug Repurposing Revenue Market Share by Application (2026-2031)

Table 33. North America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Drug Repurposing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Drug Repurposing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Drug Repurposing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Drug Repurposing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Drug Repurposing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Drug Repurposing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Drug Repurposing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Drug Repurposing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drug Repurposing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Drug Repurposing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Drug Repurposing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Astellas Pharma Company Details

Table 49. Astellas Pharma Business Overview

Table 50. Astellas Pharma Drug Repurposing Product

Table 51. Astellas Pharma Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 52. Astellas Pharma Recent Development

Table 53. Biovista Company Details

Table 54. Biovista Business Overview

Table 55. Biovista Drug Repurposing Product

Table 56. Biovista Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 57. Biovista Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Drug Repurposing Product

Table 61. Novartis Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. AbbVie Company Details

Table 64. AbbVie Business Overview

Table 65. AbbVie Drug Repurposing Product

Table 66. AbbVie Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 67. AbbVie Recent Development

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer Drug Repurposing Product

Table 71. Pfizer Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 72. Pfizer Recent Development

Table 73. Allergan Company Details

Table 74. Allergan Business Overview

Table 75. Allergan Drug Repurposing Product

Table 76. Allergan Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 77. Allergan Recent Development

Table 78. NuMedii Company Details

Table 79. NuMedii Business Overview

Table 80. NuMedii Drug Repurposing Product

Table 81. NuMedii Revenue in Drug Repurposing Business (2020-2025) & (US$ Million)

Table 82. NuMedii Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Drug Repurposing Picture

Figure 2. Global Drug Repurposing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Repurposing Market Share by Type: 2024 VS 2031

Figure 4. Oncology Features

Figure 5. CNS Diseases Features

Figure 6. Neurodegenerative Diseases Features

Figure 7. Others Features

Figure 8. Global Drug Repurposing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Drug Repurposing Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Ambulatory Surgical Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Drug Repurposing Report Years Considered

Figure 14. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Drug Repurposing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Drug Repurposing Market Share by Region: 2024 VS 2031

Figure 17. Global Drug Repurposing Market Share by Players in 2024

Figure 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2024

Figure 20. North America Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Drug Repurposing Market Share by Country (2020-2031)

Figure 22. United States Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Drug Repurposing Market Share by Country (2020-2031)

Figure 26. Germany Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Drug Repurposing Market Share by Region (2020-2031)

Figure 34. China Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Drug Repurposing Market Share by Country (2020-2031)

Figure 42. Mexico Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Drug Repurposing Market Share by Country (2020-2031)

Figure 46. Turkey Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Drug Repurposing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Astellas Pharma Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 50. Biovista Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 52. AbbVie Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 54. Allergan Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 55. NuMedii Revenue Growth Rate in Drug Repurposing Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Repositioning Market Insights Forecast to 2030

Drug Repositioning Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Repurposing Serveice Market Research Report 2025

Drug Reprofiling Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Reconstitution System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Reconstitution Device Market Research Report 2025

Global Novel Drug Reconstitution System Market Research Report 2024

Outsourcing Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2025

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Reconstitution Drug Delivery System Market Research Report 2025

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Global Sildenafil Drug Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions